Price T Rowe Associates Inc Atara Biotherapeutics, Inc. Transaction History

Price T Rowe Associates Inc

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$0.44 - $1.22 $2.16 Million - $5.98 Million	4,903,159 Added 8916.29%	4,958,150 $3.44 Million
Q3 2023 Nov 14, 2023	SELL	$1.41 - $2.31 $30,502 - $49,972	-21,633 Reduced 28.23%	54,991 $82,000
Q2 2023 Aug 14, 2023	BUY	$1.5 - $3.04 $2,637 - $5,344	1,758 Added 2.35%	76,624 $124,000
Q1 2023 May 15, 2023	SELL	$2.8 - $5.46 $18,104 - $35,304	-6,466 Reduced 7.95%	74,866 $218,000
Q4 2022 Feb 14, 2023	SELL	$2.85 - $5.18 $73,025 - $132,727	-25,623 Reduced 23.96%	81,332 $267,000
Q3 2022 Nov 14, 2022	BUY	$2.85 - $8.73 $179,094 - $548,593	62,840 Added 142.45%	106,955 $405,000
Q2 2022 Aug 15, 2022	BUY	$4.69 - $9.84 $72,394 - $151,890	15,436 Added 53.82%	44,115 $344,000
Q1 2022 May 16, 2022	BUY	$8.44 - $16.89 $52,142 - $104,346	6,178 Added 27.46%	28,679 $266,000
Q4 2021 Feb 14, 2022	SELL	$14.7 - $19.89 $172,401 - $233,269	-11,728 Reduced 34.26%	22,501 $355,000
Q3 2021 Nov 15, 2021	BUY	$11.99 - $17.9 $2,350 - $3,508	196 Added 0.58%	34,229 $613,000
Q2 2021 Aug 16, 2021	BUY	$12.89 - $16.58 $62,851 - $80,844	4,876 Added 16.72%	34,033 $529,000
Q1 2021 May 17, 2021	BUY	$14.0 - $20.72 $4,536 - $6,713	324 Added 1.12%	29,157 $419,000
Q4 2020 Feb 16, 2021	BUY	$12.67 - $26.23 $365,314 - $756,289	28,833 New	28,833 $566,000

2.89M

Ticker ATRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,362,304
Market Cap $1.15B
Description
Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

Stay updated on Price T Rowe Associates Inc with notifications on news.